Abnormal Uterine Bleeding: - Rou'a Eyad - Rahaf Eyad
Abnormal Uterine Bleeding: - Rou'a Eyad - Rahaf Eyad
Abnormal Uterine Bleeding: - Rou'a Eyad - Rahaf Eyad
- Rou’a Eyad
- Rahaf Eyad
Outlines
Normal uterine bleeding.
AUB “ Definition & terminology”
AUB Causes “ FIGO classification”
DUB
What is a normal uterine bleeding ?
Menstruation
The menstrual cycle:
1-Regular:
Duration (3-7 days )
Frequency (21-35 day)
Amount : 50 - 80 ml ( not more than 80 ml )
* Frequency
* Regularity
* Duration : short/long
* Volume: change in hemodynamic status
Terminology related to menstrual disorder:
• Disorder of ovulation:
-Oligoovulation: Cycles of more than 35 days / less than 8 cycles a year.
- Anovulation: Absence of ovulation.
• Disturbances of regularity:
- Irregular Menstrual Bleeding: Abnormal variations in the length of
menstrual cycle
- Absent Menstrual Bleeding(Amenorrhea):No menstruation in a 90 day period.
• Disorder of length of cycle (frequency):
- Polymenorrhea: Menstruation occurring less than 21 days (frequent menses)
- Oligomenorrhea: Menstruation occurring more than 35 days (infrequent menses)
• Disorder of amount of flow:
-Menorrhagia: ↑in amount flow to 90 ml or more per cycle
- Hypomenorrhea: ↓ in amount of flow to less than 30 ml per cycle
- Diagnosis:
Urine or serum β-hCG test is required to confirm pregnancy.
If pregnancy is identified vaginal ultrasound will help sort out which
pregnancy complication is operative.
If pregnancy test is NIGATIVE:
FIGO classification of AUB: PALM-COEIN
PALM COIN
structural causes
PALM
Structural/ Anatomic lesion:
The classic history is that of unpredictable bleeding (without cramping) occurring
between normal, predictable menstrual periods (with cramping).
A variety of lower and upper reproductive tract factors can cause bleeding:
o Vaginal lesions: lacerations, varicosities or tumors.
o Cervical lesions: polyps, cervicitis or tumors.
o Endometrial lesions: submucous leiomyomas, polyps, hyperplasia or cancer.
o Myometrial lesions: adenomyosis.
P A L M
Palm- Polyps
• localized overgrowths of endometrial tissue ,containing
glands, stroma , and blood vessels , covered with epithelium .
• Most commonly found in reproductive age women
• key role in their development : estrogen stimulation
• Usually benign .
• Treatment for women with symptomatic polyps: operative
hysteroscopy
P A L M
pAlm- ADENOMYOSIS
• presence of endometrial glands and stroma in the
uterine myometrium . → ectopic endometrial tissue
leads to hypertrophy of the surrounding myometrium .
palm- LEIOMYOMA
• A.k.A fibroids
• Benign tumors of the uterine myometrium
• Mechanisms by which fibroids cause abnormal bleeding
are varied and depend on size , location , and number :
- Intracavitary / submucous fibroids
- intramural fibroids
- Subserous fibroids Medical
• management Surgical : hysterectomy , myomectomy
P A L M
palM: Malignancy
• In any part of genital tract
• Bleeding from cervical malignancy classically presents
as coital bleeding or intermenstrual bleeding
• mostly secondary to prolonged exposure to
hyperestrogenic state (chronic anovulation , PCOS ,
obesity , nulligravidity)
• Lynch syndrome ,carries a 40 % to 50 % lifetime risk of
endometrial cancer ( mostly before the age of 45. )
• Diagnosis:
A number of tests can be used to for anatomic diagnosis.
• Lower genital tract: pelvic and speculum exam
• Upper genital tract: saline sonogram, endometrial biopsy,
or hysteroscopy
• Management:
Varies according to the individual diagnosis.
NON structural causes
COEIN
Coein- coagulopathy
Up to 15% of patients with AUB (especially in the adolescent age group)
have coagulopathies.
positive for other bleeding symptoms including epistaxis, gingival bleeding,
and ecchymosis.
can be due to: vessel wall disorders, platelet disorders, coagulation disorders, and
fibrinolytic disorders
Von Willebrand disease
- the most common hereditary coagulation abnormality.
- arises from a deficiency of von Willebrand factor (vWF), a protein required
for platelet adhesion.
Diagnosis.
- Positive family history
- review of systems
- Lab tests include CBC with platelet count, PT, and PTT.
- vWF antigen.(Von Willebrand disease).
Management.
Consultation with a hematology specialist
COein- Ovulatory dysfunction
Common cause of bleeding in pubertal girl and perimenopausal women .
Disorder of hypothalamic-pituitary-gonadal axis ,PCOS, Obesity.
Oligomenorrhea followed by heavy bleeding.
CoEin- Endometrial causes
imbalance of PGs.
endometritis /continuous release of PGs
CoeIn-Iatrogenic
most common are hormonal preparations
Oral contraceptives, progesterone, IUD implant-related bleeding, GnRH
agonist and antagonist, SERM, SPRM.
Cigarette smoking: reduce the level of steroid because of enhanced hepatic
metabolism .
Interactions between oral contraceptives and other medications , such as
antibiotics and anticonvulsants may alter circulating levels of steroids ,
allowing follicular recruitment and increased endogenous levels of estrogen .
Drugs that interfere with dopamine metabolism such serotonin intake
inhibitor
Use of anticoagulant drug
CoeiN-Not yet claciffied
results in,
necrosis, and an orderly shedding of the
PG release
endometrium.
DUB
Correctable causes of anovulation:
- Anovulation can be secondary to other medical conditions.
Hypothyroidism is a common cause of anovulation, diagnosed by a high TSH and
treated with thyroid replacement.
Hyperprolactinemia, diagnosed by a serum prolactin test. An elevated prolactin
inhibits GnRH. Treatment depends on the cause of the elevated prolactin.
DUB
Management:
Progestin management:
o Treatment involves replacing the hormone which is lacking. These methods
help regulate the menstrual flow and prevent endometrial hyperplasia, but do
not re-establish normal ovulation
o Cyclic MPA (Medroxyprogesterone acetate): can be administered for the last
7 to 10 days of each cycle.
o Oral contraceptive pills (OCs): Estrogen-progestin oral contraceptives are
often used for convenience.
o Progestin intrauterine system (LNG-IUS): The levonorgestrel lUS (Mirena)
delivers the progestin directly to the endometrium.
DUB
Management:
Other managements:
If progestin management is not successful in
controlling blood loss, the following generic methods have been
successful:
Tranexamic acid: works by inhibiting fibrinolysis by plasmin. It is
contraindicated with history of DVT, PE or CVA, and not
recommended with E+P steroids.
Endometrial ablation: procedure destroys the endometrium by
heat, cold or microwaves. It leads to iatrogenic Asherman syndrome
and minimal or no menstrual blood loss. Fertility will be affected.
Hysterectomy: is a last resort and performed only after all other
therapies have been unsuccessful.